Kalender

» zurück zur Übersicht

2017 | 21.–22. September, Toronto

International Conference on Clinical and Medical Genetics

 

About The Conference

Clinical Genetics-2016 welcomes all the attendees, speakers, sponsor’s and other research expertise from all over the world to the "International conference on Clinical and Medical Genetics (Clinical Genetics 2016)" which is going to be held during November 28-302016 in Atlanta, USA. We are very much honored to invite you all to exchange and share your views and experience on the Current Advancements and Novel Research on Clinical and Medical Genetics.

OMICS International Organizes Clinical Genetics 2016 conference along with 300+ Conferences across USA, Europe & Asia every year with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities as editorial board members.

We invite you to join us at the Clinical Genetics 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Clinical Genetics 2016 organizing committee look forward to meeting you in Atlanta, USA.

Clinical and Medical genetics is involved in the diagnosis and management of hereditary disorders which determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens which are intended for human use and also be used for prevention, treatment, diagnosis or for relieving symptoms of a disease. There is a rapid growth in the field of Clinical and Molecular Genetics because of the increased prevalence of infectious diseases, causative mutating organisms which led to the discovery of novel clinical and genetic testing methods.  The Genetic testing market sale is estimated to reach $25 billion annually by 2021 with a growth rate of 10% in the United States. The genetic testing market is believed to reach approximately $60 billion by 2020 globally. US represent the largest market for genetic testing worldwide.

The global market for DNA sequencing products and services in 2012 was $3.5 billion and $4.5 billion in 2013. It is expected to reach $11.7 billion by 2018 with a CAGR of 21.2%.

Website der Veranstaltung: www.genetics.conferenceseries.com/